Apollo Hospitals Chennai organises international CME programme for

Apollo Hospitals Chennai, in collaboration with Apollo Clinic Dhanmondi, Dhaka (Licensee: JMI Specialized Hospital PLC), organised an International Continuing Medical Education (CME) Programme for Doctors on Thursday at Apollo Clinic Dhanmondi, Dhaka.

The event brought together nearly 100 Bangladeshi medical students, postgraduate residents, and consultant physicians to exchange knowledge with internationally renowned experts in pediatric urology surgery and pediatric orthopedic surgery, according to a press release.

The CME programme was held at the premises of Apollo Clinic Dhanmondi and featured two scientific sessions titled "Current Concepts in Hip Disorders and Malignant Bone Tumors in Children" and "A Paradigm Shift in Pediatric Urology."

The keynote presentations were delivered by Dr Jimmy Shad, an experienced Pediatric Urology Surgeon and Dr Shankar R, Pediatric Orthopedic Surgeon from Apollo Hospitals Chennai. The programme was moderated by Dr Tamjeed Alam, Chief Executive Officer of Apollo Clinic Dhanmondi.

This CME programme further strengthened the growing collaboration between JMI Specialized Hospital PLC, one of Bangladesh's leading healthcare providers, and Apollo Hospitals, a renowned South Asian healthcare network with more than 76 hospitals and 700+ clinics across multiple countries.

The partnership aims to provide Bangladeshi patients with reliable, world-class healthcare services locally at an affordable cost, reducing the need to seek treatment abroad while contributing to the advancement of Bangladesh's healthcare sector.

The long-term collaboration also seeks to support Bangladesh's potential as an emerging destination for medical tourism.

During the event, Apollo Clinic Dhanmondi also highlighted several of its key clinical achievements, including serving more than 22,000 outpatient (OPD) patients, treating over 2,500 inpatient (IPD) cases, and successfully performing more than 1,000 surgical procedures. The clinic further reported a surgical site infection (SSI) rate of less than 1%, reflecting its commitment to maintaining high standards of patient safety and quality care.